Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)

Background Direct-acting antivirals (DAAs) are safe and effective for the treatment of HCV infection. However, data regarding their efficacy in patients with Child–Pugh B cirrhosis are scarce and their capability in improving liver function is debated. The aim of our study was to assess the clinical...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hepatology international 2019-01, Vol.13 (1), p.66-74
Hauptverfasser:	Gentile, Ivan, Scotto, Riccardo, Coppola, Carmine, Staiano, Laura, Amoruso, Daniela Caterina, De Simone, Teresa, Portunato, Federica, De Pascalis, Stefania, Martini, Salvatore, Macera, Margherita, Viceconte, Giulio, Tosone, Grazia, Buonomo, Antonio Riccardo, Borgia, Guglielmo, Coppola, Nicola
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral agents Antiviral drugs Cirrhosis Clinical outcomes Colorectal Surgery Genotypes Hepatology Liver Liver cirrhosis Medicine Medicine & Public Health Original Article Patients Quality of life Surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!